CA777769A
(en)
|
1963-03-18 |
1968-02-06 |
H. Roy Clarence |
Substituted methylene diphosphonic acid compounds and detergent compositions
|
US3239345A
(en)
|
1965-02-15 |
1966-03-08 |
|
Estrogenic compounds and animal
growth promoters |
US4411890A
(en)
|
1981-04-14 |
1983-10-25 |
Beckman Instruments, Inc. |
Synthetic peptides having pituitary growth hormone releasing activity
|
US3865801A
(en)
|
1973-06-15 |
1975-02-11 |
Atomic Energy Commission |
Stabilization of urinary erythropoietin using sodium p-aminosalicylate and extracting into phenol
|
US4036979A
(en)
|
1974-01-25 |
1977-07-19 |
American Cyanamid Company |
Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
|
US4342767A
(en)
|
1980-01-23 |
1982-08-03 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products
|
US4444784A
(en)
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
DK149080C
(da)
|
1980-06-06 |
1986-07-28 |
Sankyo Co |
Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
|
EP0089139A2
(en)
|
1982-03-16 |
1983-09-21 |
Beecham Group Plc |
Antibiotics, their preparation and use
|
FR2531088B1
(fr)
|
1982-07-29 |
1987-08-28 |
Sanofi Sa |
Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
|
US5354772A
(en)
|
1982-11-22 |
1994-10-11 |
Sandoz Pharm. Corp. |
Indole analogs of mevalonolactone and derivatives thereof
|
GB8332704D0
(en)
|
1983-12-07 |
1984-01-11 |
Pfizer Ltd |
Growth promotants for animals
|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
US4729999A
(en)
|
1984-10-12 |
1988-03-08 |
Bcm Technologies |
Antiestrogen therapy for symptoms of estrogen deficiency
|
US4761406A
(en)
|
1985-06-06 |
1988-08-02 |
The Procter & Gamble Company |
Regimen for treating osteoporosis
|
DE3623397A1
(de)
|
1986-07-11 |
1988-01-14 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
CA1339805C
(en)
|
1988-01-20 |
1998-04-07 |
Yasuo Isomura |
(cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
|
AU637316B2
(en)
|
1988-01-28 |
1993-05-27 |
Eastman Kodak Company |
Polypeptide compounds having growth hormone releasing activity
|
DE68919213T2
(de)
|
1988-01-28 |
1995-05-11 |
Polygen Holding Corp |
Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität.
|
US4922007A
(en)
|
1989-06-09 |
1990-05-01 |
Merck & Co., Inc. |
Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
AU646822B2
(en)
|
1989-10-13 |
1994-03-10 |
Kirin-Amgen Inc. |
Erythropoietin isoforms
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
US5019651A
(en)
|
1990-06-20 |
1991-05-28 |
Merck & Co., Inc. |
Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
|
US5177080A
(en)
|
1990-12-14 |
1993-01-05 |
Bayer Aktiengesellschaft |
Substituted pyridyl-dihydroxy-heptenoic acid and its salts
|
US5206235A
(en)
|
1991-03-20 |
1993-04-27 |
Merck & Co., Inc. |
Benzo-fused lactams that promote the release of growth hormone
|
JP2648897B2
(ja)
|
1991-07-01 |
1997-09-03 |
塩野義製薬株式会社 |
ピリミジン誘導体
|
US5217994A
(en)
|
1991-08-09 |
1993-06-08 |
Merck & Co., Inc. |
Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
|
US5204350A
(en)
|
1991-08-09 |
1993-04-20 |
Merck & Co., Inc. |
Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives
|
US5663146A
(en)
|
1991-08-22 |
1997-09-02 |
Administrators Of The Tulane Educational Fund |
Polypeptide analogues having growth hormone releasing activity
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
US5283241A
(en)
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5583130A
(en)
|
1992-09-25 |
1996-12-10 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5317017A
(en)
|
1992-09-30 |
1994-05-31 |
Merck & Co., Inc. |
N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
|
US5374721A
(en)
|
1992-10-14 |
1994-12-20 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
WO1994011012A1
(en)
|
1992-11-06 |
1994-05-26 |
Merck & Co., Inc. |
Substituted dipeptide analogs promote release of growth hormone
|
NZ258412A
(en)
|
1992-12-11 |
1997-01-29 |
Merck & Co Inc |
Spiro-fused piperidine derivatives and pharmaceutical compositions
|
US5578593A
(en)
|
1992-12-11 |
1996-11-26 |
Merck & Co., Inc. |
Spiro piperidines and homologs promote release of growth hormone
|
US5284841A
(en)
|
1993-02-04 |
1994-02-08 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5434261A
(en)
|
1993-07-26 |
1995-07-18 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5430144A
(en)
|
1993-07-26 |
1995-07-04 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5952281A
(en)
|
1993-08-04 |
1999-09-14 |
Colgate Palmolive Company |
Aqueous cleaning composition which may be in microemulsion form containing a silicone antifoam agent
|
TW257765B
(ja)
|
1993-08-25 |
1995-09-21 |
Merck & Co Inc |
|
US5510517A
(en)
|
1993-08-25 |
1996-04-23 |
Merck & Co., Inc. |
Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
|
US5631365A
(en)
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
DE4332384A1
(de)
|
1993-09-23 |
1995-03-30 |
Merck Patent Gmbh |
Adhäsionsrezeptor-Antagonisten III
|
US5545735A
(en)
|
1993-10-04 |
1996-08-13 |
Merck & Co., Inc. |
Benzo-Fused Lactams promote release of growth hormone
|
HUT75224A
(en)
|
1993-10-19 |
1997-04-28 |
Merck & Co Inc |
Combination of bisphosphonates and growth hormone secretagogues
|
US5438136A
(en)
|
1993-11-02 |
1995-08-01 |
Merck & Co., Inc. |
Benzo-fused macrocycles promote release of growth hormone
|
US5492916A
(en)
|
1993-12-23 |
1996-02-20 |
Merck & Co., Inc. |
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
PL322706A1
(en)
|
1993-11-09 |
1998-02-16 |
Merck & Co Inc |
Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation
|
US5494919A
(en)
|
1993-11-09 |
1996-02-27 |
Merck & Co., Inc. |
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
AU684878B2
(en)
|
1993-11-24 |
1998-01-08 |
Merck & Co., Inc. |
Compounds and the use thereof to promote the release of growth hormone(s)
|
WO1995016675A1
(en)
|
1993-12-13 |
1995-06-22 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5606054A
(en)
|
1993-12-14 |
1997-02-25 |
Merck & Co., Inc. |
Heterocyclic-fused lactams promote release of growth hormone
|
US5767085A
(en)
|
1993-12-23 |
1998-06-16 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
AU683121B2
(en)
|
1993-12-23 |
1997-10-30 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
US5501969A
(en)
|
1994-03-08 |
1996-03-26 |
Human Genome Sciences, Inc. |
Human osteoclast-derived cathepsin
|
AU701776B2
(en)
|
1994-05-27 |
1999-02-04 |
Merck & Co., Inc. |
Compounds for inhibiting osteoclast-mediated bone resorption
|
US5777112A
(en)
|
1994-06-13 |
1998-07-07 |
Merck & Co., Inc |
Piperazine compounds promote release of growth hormone
|
JPH10504807A
(ja)
|
1994-06-29 |
1998-05-12 |
スミスクライン・ビーチャム・コーポレイション |
ビトロネクチン受容体拮抗剤
|
MX9700041A
(es)
|
1994-06-29 |
1997-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptor de vitronectina.
|
US5639754A
(en)
|
1994-07-12 |
1997-06-17 |
Janssen Pharmaceutica N.V. |
Urea and thiourea derivatives of azolones
|
WO1996002530A1
(en)
|
1994-07-20 |
1996-02-01 |
Merck & Co., Inc. |
Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
|
US5494920A
(en)
|
1994-08-22 |
1996-02-27 |
Eli Lilly And Company |
Methods of inhibiting viral replication
|
WO1996006087A1
(en)
|
1994-08-22 |
1996-02-29 |
Smithkline Beecham Corporation |
Bicyclic compounds
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
US5736357A
(en)
|
1994-10-27 |
1998-04-07 |
Arris Pharmaceutical |
Cathespin O protease
|
US6544767B1
(en)
|
1994-10-27 |
2003-04-08 |
Axys Pharmaceuticals, Inc. |
Cathespin O2 protease
|
WO1996026190A1
(en)
|
1995-02-22 |
1996-08-29 |
Smithkline Beecham Corporation |
Integrin receptor antagonists
|
US5710159A
(en)
|
1996-05-09 |
1998-01-20 |
The Dupont Merck Pharmaceutical Company |
Integrin receptor antagonists
|
US5780426A
(en)
|
1995-06-07 |
1998-07-14 |
Ixsys, Incorporated |
Fivemer cyclic peptide inhibitors of diseases involving αv β3
|
SI0910563T1
(en)
|
1995-06-29 |
2003-10-31 |
Smithkline Beecham Corporation |
Integrin receptor antagonists
|
US6008213A
(en)
|
1995-06-29 |
1999-12-28 |
Smithkline Beecham Corporation |
Integrin receptor antagonists
|
ES2161373T3
(es)
|
1995-08-30 |
2001-12-01 |
Searle & Co |
Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas.
|
GB9518953D0
(en)
|
1995-09-15 |
1995-11-15 |
Pfizer Ltd |
Pharmaceutical formulations
|
PT814782E
(pt)
|
1995-12-22 |
2003-04-30 |
Nissan Chemical Ind Ltd |
Composicao farmaceutica estabilizada com um agente basico
|
US5760028A
(en)
|
1995-12-22 |
1998-06-02 |
The Dupont Merck Pharmaceutical Company |
Integrin receptor antagonists
|
EP0906103A1
(en)
|
1995-12-29 |
1999-04-07 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
JP2000502354A
(ja)
|
1995-12-29 |
2000-02-29 |
スミスクライン・ビーチャム・コーポレイション |
ビトロネクチン受容体アンタゴニスト
|
KR19990076876A
(ko)
|
1995-12-29 |
1999-10-25 |
스티븐 베네티아너 |
비트로넥틴 수용체 길항제
|
ATE207889T1
(de)
|
1996-03-20 |
2001-11-15 |
Aventis Pharma Sa |
Trizyclische verbindungen mit wirkung auf integrine, besonders auf das alphavbeta3-integrin,verfahren zur ihrer herstellung und zwischenprodukte des verfahrens, ihre verwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
|
DE59706273D1
(de)
|
1996-03-20 |
2002-03-21 |
Hoechst Ag |
Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
|
CA2250690A1
(en)
|
1996-03-29 |
1997-10-09 |
G.D. Searle & Co. |
Cinnamic acid derivatives and their use as integrin antagonists
|
AU2323897A
(en)
|
1996-03-29 |
1997-10-22 |
G.D. Searle & Co. |
Cyclopropyl alkanoic acid derivatives
|
EP0889876B1
(en)
|
1996-03-29 |
2001-07-25 |
G.D. SEARLE & CO. |
Meta-substituted phenylene sulphonamide derivatives
|
CA2250464A1
(en)
|
1996-03-29 |
1997-10-09 |
G.D. Searle & Co. |
Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
|
US5925655A
(en)
|
1996-04-10 |
1999-07-20 |
Merck & Co., Inc. |
αv β3 antagonists
|
EP0901373B1
(en)
|
1996-04-10 |
2002-11-06 |
Merck & Co., Inc. |
Alpha v Beta 3 ANTAGONISTS
|
EP0907637A1
(de)
|
1996-06-28 |
1999-04-14 |
MERCK PATENT GmbH |
Phenylalanin-derivate als integrin-inhibitoren
|
DE19629816A1
(de)
|
1996-07-24 |
1998-01-29 |
Hoechst Ag |
Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
|
DE19629817A1
(de)
|
1996-07-24 |
1998-01-29 |
Hoechst Ag |
Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
|
AU724191B2
(en)
|
1996-08-29 |
2000-09-14 |
Merck & Co., Inc. |
Integrin antagonists
|
US5981546A
(en)
|
1996-08-29 |
1999-11-09 |
Merck & Co., Inc. |
Integrin antagonists
|
UA60311C2
(uk)
|
1996-10-02 |
2003-10-15 |
Смітклайн Бічам Корпорейшн |
Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
|
WO1998015278A1
(en)
|
1996-10-07 |
1998-04-16 |
Smithkline Beecham Corporation |
Method for stimulating bone formation
|
EP0946164A4
(en)
|
1996-10-30 |
2000-08-23 |
Merck & Co Inc |
INTEGRIN ANTAGONISTS
|
US5919792A
(en)
|
1996-10-30 |
1999-07-06 |
Merck & Co., Inc. |
Integrin antagonists
|
DE69720771T2
(de)
|
1996-10-30 |
2004-01-29 |
Merck & Co Inc |
Integrin antagonist
|
US5952341A
(en)
|
1996-10-30 |
1999-09-14 |
Merck & Co., Inc. |
Integrin antagonists
|
WO2000035298A1
(en)
|
1996-11-27 |
2000-06-22 |
Wm. Wrigley Jr. Company |
Chewing gum containing medicament active agents
|
WO1998023608A1
(en)
|
1996-11-27 |
1998-06-04 |
Dupont Pharmaceuticals Company |
Novel integrin receptor antagonists
|
WO1998025892A1
(en)
|
1996-12-09 |
1998-06-18 |
Eli Lilly And Company |
Integrin antagonists
|
DE19653645A1
(de)
|
1996-12-20 |
1998-06-25 |
Hoechst Ag |
Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
|
DE19653647A1
(de)
|
1996-12-20 |
1998-06-25 |
Hoechst Ag |
Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
|
US6218387B1
(en)
|
1996-12-20 |
2001-04-17 |
Hoechst Aktiengesellschaft |
Vitronectin receptor anatagonists, their preparation and their use
|
DE19653646A1
(de)
|
1996-12-20 |
1998-06-25 |
Hoechst Ag |
Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
|
CO4920232A1
(es)
|
1997-01-08 |
2000-05-29 |
Smithkline Beecham Corp |
Acidos aceticos dibenzo [a,d] cicloheptano con actividad antagonista del receptor de vitronectin
|
JP2001509176A
(ja)
|
1997-01-17 |
2001-07-10 |
メルク エンド カンパニー インコーポレーテッド |
インテグリンアンタゴニスト
|
US6017925A
(en)
|
1997-01-17 |
2000-01-25 |
Merck & Co., Inc. |
Integrin antagonists
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
DE69839338T2
(de)
|
1997-02-05 |
2008-07-10 |
Warner-Lambert Company Llc |
Pyrido (2,3-d) pyrimidine und 4-amino-pyrimidine als inhibitoren der zellulären proliferation
|
US6559144B2
(en)
|
1997-02-13 |
2003-05-06 |
Merck Patent Gesellschaft Mit |
Bicyclic amino acids
|
DE19705450A1
(de)
|
1997-02-13 |
1998-08-20 |
Merck Patent Gmbh |
Bicyclische aromatische Aminosäuren
|
GB9711643D0
(en)
|
1997-06-05 |
1997-07-30 |
Janssen Pharmaceutica Nv |
Glass thermoplastic systems
|
US6239138B1
(en)
|
1997-07-25 |
2001-05-29 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonist
|
AU8689798A
(en)
|
1997-08-04 |
1999-02-22 |
Smithkline Beecham Corporation |
Integrin receptor antagonists
|
JP2001514253A
(ja)
|
1997-09-04 |
2001-09-11 |
スミスクライン・ビーチャム・コーポレイション |
インテグリンレセプターアンタゴニスト
|
DZ2609A1
(fr)
|
1997-09-19 |
2003-03-01 |
Smithkline Beecham Corp |
Composés nouveaux antagonistes des récepteurs de vitronectine et compositions pharmaceutiques les contenant.
|
CA2304000A1
(en)
|
1997-09-24 |
1999-04-01 |
William E. Bondinell |
Vitronectin receptor antagonist
|
FR2768736B1
(fr)
|
1997-09-24 |
2000-05-26 |
Roussel Uclaf |
Nouveaux composes tricycliques, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
|
EP1017387A4
(en)
|
1997-09-24 |
2004-08-18 |
Smithkline Beecham Corp |
VITRONEECT RECEPTOR ANTAGONIST
|
FR2768734B1
(fr)
|
1997-09-24 |
2000-01-28 |
Roussel Uclaf |
Nouveaux composes tricycliques, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
|
JP2001524481A
(ja)
|
1997-11-26 |
2001-12-04 |
デュポン ファーマシューティカルズ カンパニー |
αVβ3アンタゴニストとしての1,3,4−チアジアゾール類および1,3,4−オキサジアゾール類
|
US6048861A
(en)
|
1997-12-17 |
2000-04-11 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
WO1999031099A1
(en)
|
1997-12-17 |
1999-06-24 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
AU736026B2
(en)
|
1997-12-17 |
2001-07-26 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
US6017926A
(en)
|
1997-12-17 |
2000-01-25 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
EP1044001B1
(en)
|
1997-12-17 |
2005-07-06 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
US6066648A
(en)
|
1997-12-17 |
2000-05-23 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
EP0933367A1
(en)
|
1997-12-19 |
1999-08-04 |
Hoechst Marion Roussel Deutschland GmbH |
Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
|
AU1687699A
(en)
|
1997-12-25 |
1999-07-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivatives
|
SI0928790T1
(en)
|
1998-01-02 |
2003-06-30 |
F. Hoffmann-La Roche Ag |
Thiazole derivatives
|
EP0928793B1
(en)
|
1998-01-02 |
2002-05-15 |
F. Hoffmann-La Roche Ag |
Thiazole derivatives
|
NZ505613A
(en)
|
1998-01-23 |
2002-11-26 |
Aventis Pharma Gmbh |
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
|
ZA994406B
(en)
|
1998-03-04 |
2000-02-11 |
Searle & Co |
Meta-azacyclic amino benzoic acid and derivatives thereof.
|
KR20010041812A
(ko)
|
1998-03-10 |
2001-05-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
비트로넥틴 수용체 길항제
|
US6420558B1
(en)
|
1998-04-09 |
2002-07-16 |
Meiji Seika Kaisha, Ltd. |
Aminopiperidine derivates as integrin αvβ3 antagonists
|
CN1304406A
(zh)
|
1998-04-10 |
2001-07-18 |
G·D·瑟尔公司 |
作为玻连蛋白拮抗剂的杂环甘氨酰β-丙氨酸衍生物
|
WO1999052879A1
(en)
|
1998-04-14 |
1999-10-21 |
American Home Products Corporation |
Acylresorcinol derivatives as selective vitronectin receptor inhibitors
|
EP0960882A1
(en)
|
1998-05-19 |
1999-12-01 |
Hoechst Marion Roussel Deutschland GmbH |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
|
AU4385399A
(en)
|
1998-06-29 |
2000-01-17 |
Biochem Pharma Inc. |
Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
|
SK18822000A3
(sk)
|
1998-07-06 |
2001-12-03 |
Bristol-Myers Squibb Company |
Bifenylsulfónamidy ako duálne antagonisty angiotenzínového a endotelínového receptora
|
DE19831710A1
(de)
|
1998-07-15 |
2000-01-20 |
Merck Patent Gmbh |
Diacylhydrazinderivate
|
EP1100506A4
(en)
|
1998-07-29 |
2002-06-26 |
Merck & Co Inc |
INTEGRIN RECEPTOR ANTAGONISTS
|
CA2338878A1
(en)
|
1998-08-13 |
2000-02-24 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
WO2001017562A1
(en)
|
1999-09-02 |
2001-03-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Osteogenesis promoting agents
|
DE60132975T2
(de)
|
2000-01-06 |
2009-02-26 |
Merck Frosst Canada Inc., Kirkland |
Neue substanzen und verbindungen als protease-inhibitoren
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
CA2404630A1
(en)
|
2000-04-06 |
2001-10-18 |
Merck Frosst Canada & Co. |
Cathepsin cysteine protease inhibitors
|
JP4426792B2
(ja)
*
|
2002-08-12 |
2010-03-03 |
武田薬品工業株式会社 |
縮合ベンゼン誘導体および用途
|
JP2007505164A
(ja)
*
|
2003-06-10 |
2007-03-08 |
スミスクライン ビーチャム コーポレーション |
アンドロゲン、グルココルチコイド、ミネラルコルチコイドおよびプロゲステロン受容体のモジュレーターとしての1−アミノナフタレン類
|
MXPA06001751A
(es)
*
|
2003-08-22 |
2006-05-12 |
Ligand Pharm Inc |
Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno.
|
CA2566942A1
(en)
*
|
2004-05-17 |
2005-12-08 |
Acadia Pharmaceuticals Inc. |
Androgen receptor modulators and method of treating disease using the same
|
EP2222636B1
(en)
*
|
2007-12-21 |
2013-04-10 |
Ligand Pharmaceuticals Inc. |
Selective androgen receptor modulators (sarms) and uses thereof
|
MX2010009162A
(es)
*
|
2008-02-22 |
2010-12-21 |
Radius Health Inc |
Moduladores selectivos del receptor de androgeno.
|
MY176727A
(en)
*
|
2012-12-03 |
2020-08-20 |
Pfizer |
Selective androgen receptor modulators
|
US9920043B2
(en)
*
|
2014-05-15 |
2018-03-20 |
Pfizer Inc. |
Crystalline form of 6-[(4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]iosoquinoline-1-carbonitrile
|